Skip to main content
OpenTrials
Completed

NCT Number: NCT01994356

Physician Self Disclosure of IUC Use

As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception Behavior Personal Satisfaction

Age range

18 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan Medical Center

Ann Arbor, Michigan, 48109, United States

About this study

We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • reproductive age
  • currently sexually active
  • scheduled for benign gynecology visit, annual exam, or family planning visit

Exclusion criteria

  • seeking pregnancy within 1 year
  • currently using IUC
  • prior sterilization procedure
  • currently pregnant

Treatment and study plan

Physician self-disclosure of personal IUC use

Behavioral

Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling

Usual contraceptive counseling

Behavioral

all subjects recieved usual contraceptive counseling

Other names: contraceptive counseling

Primary outcomes

  1. Intrauterine contraceptive use

    Time frame: immediately following clinical encounter and at 2 months

    All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.

Secondary outcomes

  1. Satisfaction with clinical encounter

    Time frame: immediately following clinical encounter and at 2 months

    All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.

Other outcomes

  1. Satisfaction with contraceptive method

    Time frame: immediately following clinical enocunter and at 2 months

    All subjects were surveyed to determine satisfaction with their contraceptive method of choice immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

  2. Satisfaction with provider

    Time frame: immediately following clinical encounter and at 2 months

    All subjects were surveyed to determine satisfaction with their provider immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Official study title

Pilot Study of Physician Self-disclosure of Personal Intrauterine Contraceptive Use Versus Usual Counseling

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Nov 25, 2013
Registry last updated
Nov 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.